Literature DB >> 23210095

Polycystic ovary syndrome - an update.

Jacqueline Boyle1, Helena J Teede.   

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is a common condition, present in 12-21% of women of reproductive age. Up to 70% of women with PCOS remain undiagnosed.
OBJECTIVE: This article summarises the 2011 national PCOS guideline, Evidence-based guideline for the assessment and management of polycystic ovary syndrome, for the general practice context, with particular reference to the needs of Indigenous Australian women. DISCUSSION: Women with PCOS may present with a wide range of symptoms. The Rotterdam criteria are the most widely accepted for diagnosis and the national guideline references these criteria. Women with PCOS have a higher risk of metabolic syndrome and its cardiovascular sequelae. This is particularly important for Indigenous women who are already at increased baseline risk. Management of PCOS involves attention to current symptoms, fertility and psychosocial issues, as well as prevention of related future health problems including diabetes. Resources are available to help guide management and patients may benefit most from a team approach to care.

Entities:  

Mesh:

Year:  2012        PMID: 23210095

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  13 in total

1.  Functional Genetic Variation in the Anti-Müllerian Hormone Pathway in Women With Polycystic Ovary Syndrome.

Authors:  Lidija K Gorsic; Matthew Dapas; Richard S Legro; M Geoffrey Hayes; Margrit Urbanek
Journal:  J Clin Endocrinol Metab       Date:  2019-07-01       Impact factor: 5.958

Review 2.  A review on inositol's potential in cyclic disturbances of adipose-endocrinology-associated polycystic ovary syndrome.

Authors:  Waleed Hassan Almalki
Journal:  Mol Cell Biochem       Date:  2021-03-23       Impact factor: 3.396

3.  Effect of Aslagh Capsule, a Traditional Compound Herbal Product on Oligomenorrhea in Patients with Polycystic Ovary Syndrome: A Three-Arm, Open-label, Randomized, Controlled Trial.

Authors:  Maryam Bahman; Homa Hajimehdipoor; Soodabeh Bioos; Fataneh Hashem-Dabaghian; Maryam Afrakhteh; Mojgan Tansaz
Journal:  Galen Med J       Date:  2019-06-02

4.  Developmental Programming: Prenatal and Postnatal Androgen Antagonist and Insulin Sensitizer Interventions Prevent Advancement of Puberty and Improve LH Surge Dynamics in Prenatal Testosterone-Treated Sheep.

Authors:  Vasantha Padmanabhan; Almudena Veiga-Lopez; Carol Herkimer; Bachir Abi Salloum; Jacob Moeller; Evan Beckett; Rohit Sreedharan
Journal:  Endocrinology       Date:  2015-04-28       Impact factor: 4.736

Review 5.  Progressive resistance training in polycystic ovary syndrome: can pumping iron improve clinical outcomes?

Authors:  Birinder S Cheema; Lisa Vizza; Soji Swaraj
Journal:  Sports Med       Date:  2014-09       Impact factor: 11.136

6.  Comparison of efficacy of metformin and oral contraceptive combination of ethinyl estradiol and drospirenone in polycystic ovary syndrome.

Authors:  Yashasvi Suvarna; Nivedita Maity; Pramila Kalra; M C Shivamurthy
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-01-12

7.  Physical activity and mental health in women with polycystic ovary syndrome.

Authors:  Lauren K Banting; Melanie Gibson-Helm; Remco Polman; Helena J Teede; Nigel K Stepto
Journal:  BMC Womens Health       Date:  2014-03-27       Impact factor: 2.809

8.  Body mass index and gonadotropin hormones (LH & FSH) associate with clinical symptoms among women with polycystic ovary syndrome.

Authors:  Seddigheh Esmaeilzadeh; Maryam Ghanbari Andarieh; Reza Ghadimi; Mouloud Agajani Delavar
Journal:  Glob J Health Sci       Date:  2014-09-28

Review 9.  Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth.

Authors:  Joselyn Rojas; Mervin Chávez; Luis Olivar; Milagros Rojas; Jessenia Morillo; José Mejías; María Calvo; Valmore Bermúdez
Journal:  Int J Reprod Med       Date:  2014-01-28

Review 10.  Polycystic Ovary Syndrome in Adolescence.

Authors:  Rebecca Deans
Journal:  Med Sci (Basel)       Date:  2019-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.